BioCentury | Apr 1, 2020
Distillery Therapeutics

Targeting curli amyloid fiber subunits csgA and csgB to treat Salmonella

...for Medical Research, Wynnewood, Pa. email: dessains@mlhs.org CONTACT: Çagla Tükel, Temple University, Philadelphia, Pa. email: ctukel@temple.edu Claire Quang Temple University...
BioCentury | Mar 14, 2020
Translation in Brief

A peptide fusion blocker for multiple coronaviruses, the cryo-EM structure of SARS-CoV-2 main protease, plus Locus, Excision and Harvard-Dana-Farber

...1 NFE2L2 (NRF2) - Nuclear factor (erythroid-derived 2)-like 2 BioCentury Staff Locus Biosciences Inc. Harvard Medical School Dana-Farber Cancer Institute Temple University Excision...
BioCentury | Nov 22, 2019
Preclinical News

Nov. 21 Preclinical Quick Takes: Excision applies CRISPR editing to herpes, John Cunningham viruses; plus Caribou, Oligomerix, Kymab and Gladstone-Boston Univer

...Excision targets CRISPR to herpes, JC viruses Excision BioTherapeutics Inc. and collaborators at Temple University presented a...
BioCentury | Sep 19, 2019
Distillery Therapeutics

Increasing SLC8B1 expression for Alzheimer's

...published online Aug. 29, 2019 doi:10.1038/s41467-019-11813-6 CONTACT: John W. Elrod, Temple University, Philadelphia, Pa. email: elrod@temple.edu Claire Quang Temple University...
BioCentury | Aug 14, 2019
Finance

Renovacor raises $11M to advance gene therapy for rare cardiomyopathy

...the round, joined by New Leaf Venture Partners and Innogest Capital. Founded in 2013 by Temple University...
BioCentury | Jul 18, 2019
Translation in Brief

What Excision needs to demonstrate before bringing CRISPR-HIV therapy to clinic

...tested in humans. In a Nature Communications paper published July 2, University of Nebraska and Temple University...
...any CRISPR-mediated off-target effects in the mice. Elizabeth S. Eaton, Staff Writer Excision BioTherapeutics Inc. National Institutes of Health Temple University University...
BioCentury | Jul 18, 2019
Distillery Therapeutics

CRISPR plus antiretroviral therapy could remove HIV virus from cells

...Excision BioTherapeutics Inc. plans to enter the clinic with a CRISPR-based therapy it licensed from Temple University...
...DETAILS: Dash, P. Nat. Commun. ; published online July 2, 2019 doi:10.1038/s41467-019-10366-y CONTACT: Kamel Khalili, Temple University...
...kamel.khalili@temple.edu CONTACT: Howard Gendelman, University of Nebraska Medical Center, Omaha, Neb. e-mail: hegendel@unmc.edu Elizabeth S. Eaton ART CRISPR HIV Kamel Khalili Temple University University...
BioCentury | Apr 15, 2019
Distillery Therapeutics

miR-302 mimics for bacterial pneumonia

...Temple University, Philadelphia, Pa. email: ying.tian@temple.edu CONTACT: Hao Shen, University of Pennsylvania, Philadelphia, Pa. email: hshen@mail.med.upenn.edu Claire Quang Temple University University...
BioCentury | Jan 9, 2019
Distillery Therapeutics

Cardiovascular

...published online Dec. 11, 2018 doi:10.1126/scisignal.aau0144 CONTACT: Walter J. Koch, Temple University, Philadelphia, Pa. email: walter.koch@temple.edu Sandi Wong Temple University G...
BioCentury | Nov 30, 2018
Targets & Mechanisms

Souped-up CARs at ASH 2018

...small molecule stabilizer. If the boost elicits toxicity, the company can withdraw the stabilizer. 6) Temple University...
...GmbH, Bergisch Gladbach, Germany NantKwest Inc. (NASDAQ:NK), San Diego, Calif. Obsidian Therapeutics Inc., Cambridge, Mass. Temple University...
...Institute for Biomedical Sciences American Society of Hematology GEMoaB Monoclonals GmbH iCell Gene Therapeutics Miltenyi Biotec GmbH NantKwest Inc. Obsidian Therapeutics Inc. Temple University University...
Items per page:
1 - 10 of 54
BioCentury | Apr 1, 2020
Distillery Therapeutics

Targeting curli amyloid fiber subunits csgA and csgB to treat Salmonella

...for Medical Research, Wynnewood, Pa. email: dessains@mlhs.org CONTACT: Çagla Tükel, Temple University, Philadelphia, Pa. email: ctukel@temple.edu Claire Quang Temple University...
BioCentury | Mar 14, 2020
Translation in Brief

A peptide fusion blocker for multiple coronaviruses, the cryo-EM structure of SARS-CoV-2 main protease, plus Locus, Excision and Harvard-Dana-Farber

...1 NFE2L2 (NRF2) - Nuclear factor (erythroid-derived 2)-like 2 BioCentury Staff Locus Biosciences Inc. Harvard Medical School Dana-Farber Cancer Institute Temple University Excision...
BioCentury | Nov 22, 2019
Preclinical News

Nov. 21 Preclinical Quick Takes: Excision applies CRISPR editing to herpes, John Cunningham viruses; plus Caribou, Oligomerix, Kymab and Gladstone-Boston Univer

...Excision targets CRISPR to herpes, JC viruses Excision BioTherapeutics Inc. and collaborators at Temple University presented a...
BioCentury | Sep 19, 2019
Distillery Therapeutics

Increasing SLC8B1 expression for Alzheimer's

...published online Aug. 29, 2019 doi:10.1038/s41467-019-11813-6 CONTACT: John W. Elrod, Temple University, Philadelphia, Pa. email: elrod@temple.edu Claire Quang Temple University...
BioCentury | Aug 14, 2019
Finance

Renovacor raises $11M to advance gene therapy for rare cardiomyopathy

...the round, joined by New Leaf Venture Partners and Innogest Capital. Founded in 2013 by Temple University...
BioCentury | Jul 18, 2019
Translation in Brief

What Excision needs to demonstrate before bringing CRISPR-HIV therapy to clinic

...tested in humans. In a Nature Communications paper published July 2, University of Nebraska and Temple University...
...any CRISPR-mediated off-target effects in the mice. Elizabeth S. Eaton, Staff Writer Excision BioTherapeutics Inc. National Institutes of Health Temple University University...
BioCentury | Jul 18, 2019
Distillery Therapeutics

CRISPR plus antiretroviral therapy could remove HIV virus from cells

...Excision BioTherapeutics Inc. plans to enter the clinic with a CRISPR-based therapy it licensed from Temple University...
...DETAILS: Dash, P. Nat. Commun. ; published online July 2, 2019 doi:10.1038/s41467-019-10366-y CONTACT: Kamel Khalili, Temple University...
...kamel.khalili@temple.edu CONTACT: Howard Gendelman, University of Nebraska Medical Center, Omaha, Neb. e-mail: hegendel@unmc.edu Elizabeth S. Eaton ART CRISPR HIV Kamel Khalili Temple University University...
BioCentury | Apr 15, 2019
Distillery Therapeutics

miR-302 mimics for bacterial pneumonia

...Temple University, Philadelphia, Pa. email: ying.tian@temple.edu CONTACT: Hao Shen, University of Pennsylvania, Philadelphia, Pa. email: hshen@mail.med.upenn.edu Claire Quang Temple University University...
BioCentury | Jan 9, 2019
Distillery Therapeutics

Cardiovascular

...published online Dec. 11, 2018 doi:10.1126/scisignal.aau0144 CONTACT: Walter J. Koch, Temple University, Philadelphia, Pa. email: walter.koch@temple.edu Sandi Wong Temple University G...
BioCentury | Nov 30, 2018
Targets & Mechanisms

Souped-up CARs at ASH 2018

...small molecule stabilizer. If the boost elicits toxicity, the company can withdraw the stabilizer. 6) Temple University...
...GmbH, Bergisch Gladbach, Germany NantKwest Inc. (NASDAQ:NK), San Diego, Calif. Obsidian Therapeutics Inc., Cambridge, Mass. Temple University...
...Institute for Biomedical Sciences American Society of Hematology GEMoaB Monoclonals GmbH iCell Gene Therapeutics Miltenyi Biotec GmbH NantKwest Inc. Obsidian Therapeutics Inc. Temple University University...
Items per page:
1 - 10 of 54